The effect of low and high dose empagliflozin on HbA1c and lipid profile in type 2 diabetes mellitus: A real-world data

OBJECTIVE: This study aims to evaluate the efficacy and safety of the addition of 10 or 25 mg of empagliflozin to patients with type 2 diabetes mellitus using a maximum tolerable dose of metformin and gliclazide. METHODS: A total of 60 patients who had been receiving a maximum tolerable dose of metf...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozcelik, Serhat, Celik, Mehmet, Vural, Aski, Aydin, Bunyamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117635/
https://www.ncbi.nlm.nih.gov/pubmed/32259039
http://dx.doi.org/10.14744/nci.2019.22697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117635/
https://www.ncbi.nlm.nih.gov/pubmed/32259039
http://dx.doi.org/10.14744/nci.2019.22697

Ejemplares similares